Artificial intelligence and machine learning companies develop software, algorithms and computational platforms that analyse biological data, automate workflows and accelerate scientific discovery. These technologies are increasingly used across drug discovery, diagnostics, genomics and healthcare research.
This category includes companies working on:
Browse 243 UK AI and machine learning companies below.
Federated genomic data platform for secure biomedical research
Lifebit is a London-based software company providing a federated Trusted Research Environment for large-scale health and genomic data analysis. Its platform enables pharmaceutical companies, health systems, and research organisations to access, harmonise, and analyse distributed clinico-genomic datasets securely,…
Host-response biomarker test to rapidly diagnose sepsis
Profionics is a diagnostics company developing a precision molecular test for rapid sepsis detection. Its platform analyses 52 patient-invariant biomarkers spanning inflammatory, metabolic, and adaptive immune pathways, using transcriptomics, metabolomics, and lipidomics in combination with artificial intelligence.…
Generative AI platform for T cell receptor and antibody therapeutics
Etcembly is a biotech company using generative AI to discover and engineer T cell receptor and antibody therapeutics. The company's platform applies large language models to TCR sequence data to design candidates with high affinity and selectivity for cancer and autoimmune disease targets. Its lead programme, ETC-101,…
Platform making human microbiology computable for drug discovery
Outpost Bio is a biotechnology company building predictive models of human microbial ecosystems by integrating automated wet lab experimentation with machine learning. Its Lab-in-the-Loop platform generates large-scale datasets on microbe-host and microbe-drug interactions, with the aim of predicting how microbial…
AI-powered cell simulation platform targeting ageing and age-driven diseases
Shift Bioscience is a biotechnology company developing an AI-powered virtual cell platform to identify novel therapeutic targets for cellular rejuvenation. Its proprietary single-cell ageing clock measures epigenetic age at high throughput, feeding machine learning models that predict gene combinations and small…
Multiomics blood-based platform for early-stage cancer detection
Freenome is a biotechnology company developing blood-based early cancer detection tests using a multiomics platform that combines tumour and non-tumour biological signals with machine learning. The UK subsidiary, based in Nottingham, holds the autoantibody immunodiagnostic technology and cancer detection pipeline…
AI-powered biomedical evidence analysis and drug development research
rodent2human is a biomedical software company developing AI tools to support drug discovery and translational research. Its evidence-analysis platform combines scientific literature, biological databases and computational approaches to investigate therapeutic targets, mechanisms, safety signals and clinical relevance.…
AI-enabled small molecule drug discovery
PharmEnable is a Cambridge-based drug discovery company developing novel small molecule therapeutics for targets that are inaccessible to biologics, including intracellular targets and those behind the blood-brain barrier. Its proprietary platform integrates AI and advanced medicinal chemistry to explore undercharted…
AI decision support tools for blood cancer pathology diagnosis
Spotlight Pathology is a software company developing artificial intelligence decision support tools for haematopathology. Its platform applies computer vision models trained on clinical datasets to analyse digital images of lymph node and bone marrow biopsies, supporting pathologists in the diagnosis of blood cancers…
High-density e-textile sensors for AI-powered cardiac diagnostics
Polytecks is a University of Cambridge spin-out developing wearable, textile-based sensors for high-resolution bioelectrical mapping. Patented electrode arrays capture heart signals at far higher density than standard ECGs, with AI transforming the data into detailed cardiac maps within minutes to support earlier…
Microbial bioinsecticides developed through insect behavioural screening
BugBiome is an agricultural biotechnology company developing microbially derived pest control products as alternatives to synthetic pesticides. The company uses high-throughput behavioural screening to identify naturally occurring microbes that deter feeding, inhibit egg-laying or are directly toxic to crop pests. Its…
AI-driven natural product discovery for neurological therapeutics
Pangea Bio is a clinical-stage biotechnology company developing small molecule therapeutics for neurological and neuropsychiatric disorders. Its proprietary AI platform screens natural and plant-derived chemical space, integrating ethnobotanical data with machine learning to identify novel CNS drug candidates with…
AI-designed regulatory DNA sequences to boost biologics manufacturing yields
Genosys Bio is a UK biotechnology company developing AI models that learn the regulatory grammar of DNA to design improved promoter and terminator sequences for biologics manufacturing. Its platform optimises gene expression in CHO cell lines, helping increase protein yields without changing existing cells, processes…
Computational cell models for novel drug target discovery
Oppilotech is a UK biotechnology company that uses systems biology and machine learning to build high-resolution computational models of cells and bacteria. Its proprietary platform simulates biochemical pathways to identify viable drug targets and generate first-in-class discovery programmes. The company's primary…
Point-of-care HPV self-testing for cervical cancer screening
10zyme is an early-stage medical technology company developing a point-of-care self-test for high-risk human papillomavirus, integrating synthetic biology with machine learning to deliver instant results without laboratory processing. Its test screens for all 14 high-risk HPV types linked to cervical cancer,…
Transcription factor-targeting drug discovery for neurodegeneration
Scripta Therapeutics is an Oxford-based biotech company developing disease-modifying therapeutics by mapping and modulating transcription factor networks. Its platform integrates AI, imaging, and patient-derived models in a lab-in-the-loop workflow to identify compounds that restore healthy cellular states. The…
AI platform combining retinal imaging and genomics for inherited eye disease diagnosis
Eye2Gene is an AI-powered precision ophthalmology platform combining retinal imaging with genomic analysis to accelerate diagnosis of inherited retinal diseases. Using a neural network ensemble trained on tens of thousands of multimodal retinal scans, the platform predicts the likely causative gene behind a patient's…
Predictive genetic tests for cancer and cardiovascular disease
GENinCode is a clinical-stage diagnostics company developing polygenic risk assessment tests for cardiovascular disease and ovarian cancer. Its portfolio includes CE-marked molecular tests for coronary artery disease, familial hypercholesterolaemia and thrombosis risk, alongside the ROCA test for ovarian cancer…
Oncology biotech creation studio developing and spinning out cancer therapies
Cumulus Oncology is a company creation studio specialising in oncology drug discovery and development. The company identifies and sources novel cancer therapeutic assets from academic and commercial organisations, funds them, and incorporates them into newly created spin-out biotechs. Cumulus provides scientific…
AI operating system connecting pharma drug development decisions end-to-end
Perceptic is a UK software company that has built an AI platform connecting decision-making across the drug development lifecycle. Its system unifies external asset scouting, scientific evaluation of licensing candidates, indication selection for clinical trials, and clinical data analysis within a single, traceable…